OncoSec Medical To Present at Bioelectrochemistry Gordon Research Conference on July 8 and July 10

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, announces that Robert Pierce, M.D., Chief Medical Officer, and



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/TCfb35

via IFTTT